1. Kumar A, Choudhuri G, Aggarwal R. Piperacillin induced bone marrow suppression: a case report. BMC Clin Pharmacol. 2003;3:2. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 2. Reichardt P, Handrick W, Linke A, Schille R, Kiess W. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment – a retrospective analysis in 38 children with cystic fibrosis. Infection. 1999;27:355–6. [DOI via Crossref] [Pubmed] | | 3. Gerber L, Wing EJ. Life-threatening neutropenia secondary to piperacillin/tazobactam therapy. Clin Infec Dis. 1995;21:1047–8. [DOI via Crossref] | | 4. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911–8. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 5. Pérez-Vázquez A, Pastor JM, Riancho JA. Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis. 1998;27(3):650–1. [DOI via Crossref] [Pubmed] | | 6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. Method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. [DOI via Crossref] [Pubmed] | | 7. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129:886–90. [DOI via Crossref] [Pubmed] | | 8. Fass RJ, Copelan EA, Brandt JT, Moeschberger ML, Ashton JJ. Plateletmediated bleeding caused by broad spectrum penicillins. J Infect Dis. 1987;155(6):1242–8. [DOI via Crossref] [Pubmed] | |
|
|